We lead the synthetic biology industry, having developed and successfully commercialized the most Lab-to-Market™ ingredients. Our sustainable ingredients are used in thousands of top global brands, including our own family of consumer brands in Clean Beauty and Health markets.
"Steve's three decade career at ADM brings the set of skills we need as we enter a new growth stage for our Company," said
Mills joined ADM in 1979 and served in various senior treasury and accounting roles, including as Chief Financial Officer from 2008-2010. During his most recent assignment, Mills served as ADM's Senior Executive Vice President, Performance and Growth where he helped drive growth through business development and acquisitions until his retirement from ADM in February.
"Amyris is leading the way in an array of renewable chemicals and fuels. I'm looking forward to joining Amyris's extraordinary team at a time when the Company is bringing its technology to full-scale production and commercialization," said
"As we welcome Steve to
About
Forward-Looking Statements
This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as expectations for a production plant) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including those associated with any delays or failures in development, production or commercialization of products, our reliance on third parties to achieve our goals, and other risks detailed in the "Risk Factors" section of Amyris's annual report on Form 10-K filed on
pr@amyris.com
Source:
News Provided by Acquire Media
For media inquiries, please contact: info@amyris.com
For investor inquiries, please contact: investor@amyris.com